View More Recent Stories

Nov 10, 2020 04:01PM Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
Nov 10, 2020 04:01PM Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
Oct 29, 2020 09:00AM Lumos Pharma to Participate in November Investor Conferences
Oct 29, 2020 09:00AM Lumos Pharma to Participate in November Investor Conferences
Oct 27, 2020 04:01PM Lumos Pharma to Report Third Quarter 2020 Financial Results and Host a Conference Call on November 10, 2020
Oct 27, 2020 04:01PM Lumos Pharma to Report Third Quarter 2020 Financial Results and Host a Conference Call on November 10, 2020
Aug 27, 2020 09:00AM Lumos Pharma to Participate in Upcoming Investor Conferences
Aug 27, 2020 09:00AM Lumos Pharma to Participate in Upcoming Investor Conferences
Aug 13, 2020 04:01PM Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
Aug 13, 2020 04:01PM Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
Jul 28, 2020 04:01PM Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020
Jul 28, 2020 04:01PM Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020
Jul 27, 2020 04:10PM Lumos Pharma, Inc. (LUMO) Sells Priority Review Voucher (PRV) to Merck at $100M Valuation
Jul 27, 2020 04:05PM Lumos Pharma Announces Sale of Priority Review Voucher
Jul 27, 2020 04:05PM Lumos Pharma Announces Sale of Priority Review Voucher
May 28, 2020 04:01PM Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
May 28, 2020 04:01PM Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
May 27, 2020 04:27PM Lumos Pharma to Participate in the Jefferies 2020 Healthcare Conference
May 27, 2020 04:27PM Lumos Pharma to Participate in the Jefferies 2020 Healthcare Conference
May 26, 2020 10:36AM Lumos Pharma to Report First Quarter 2020 Financial Results and Host a Conference Call on May 28, 2020
May 26, 2020 10:36AM Lumos Pharma to Report First Quarter 2020 Financial Results and Host a Conference Call on May 28, 2020
Apr 24, 2020 08:00AM Lumos Pharma Hires Biotech Veteran Aaron Schuchart as Chief Business Officer
Apr 24, 2020 08:00AM Lumos Pharma Hires Biotech Veteran Aaron Schuchart as Chief Business Officer
Apr 2, 2020 04:05PM Lumos Pharma Promotes John C. McKew, PhD to Chief Operating Officer and Chief Scientific Officer
Apr 2, 2020 04:05PM Lumos Pharma Promotes John C. McKew, PhD to Chief Operating Officer and Chief Scientific Officer
Apr 1, 2020 06:02AM Form SC 13D LUMOS PHARMA, INC. Filed by: New Enterprise Associates 14, L.P.
Mar 30, 2020 08:00AM Lumos Pharma Appoints Joseph S. McCracken, DVM, MS to Board of Directors Rick Hawkins, CEO, appointed Chairman of the Board
Mar 30, 2020 08:00AM Lumos Pharma Appoints Joseph S. McCracken, DVM, MS to Board of Directors Rick Hawkins, CEO, appointed Chairman of the Board
View More Recent Stories